TAG:
clinical laboratory services
9 Pennsylvania Hospitals Tackle Lab Specimen Errors
By Joseph Burns | From the Volume XIX No. 1 – January 9, 2012 Issue
CEO SUMMARY: In this unusual collaboration, the participating Pennsylvania hospitals dramatically reduced blood specimen labeling errors. This initiative to share best practices incorporated techniques that were refined in other projects designed to reduce medical errors and improve patie…
Rosetta Genetics, Aureon Biosciences, Plus Diagnostics, Atherotech, Sequenom
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
ROSETTA GENOMICS TO LAY OFF 35 EMPLOYEES TO CUT EXPENSES AND SHIFT MORE FUNDING toward sales of its proprietary molecular tests, Rosetta Genomics says it will eliminate 35 jobs. The company, based in Israel, operates a clinical laboratory in Philadelphia, Pe…
Congress Again Considers Co-Insurance for Lab Tests
By Robert Michel | From the Volume XXVIII No. 11 – August 15, 2011 Issue
CEO SUMMARY: Congressional cost-cutters are putting the 20% patient co-pay/coinsurance requirement for lab testing back on the table. The added complication this year is that the new Joint Select Committee on Deficit Reduction is mandated to produce its own list of cuts to the Me…
How Labs Should Comply With New Signature Rule
By Robert Michel | From the Volume XVIII No. 1 – January 18, 2011 Issue
CEO SUMMARY: Across the nation, clinical laboratories and pathology groups are reacting to the new Medicare rule that requires a physician signature on a paper requisition for clinical laboratory tests. Laboratories using paper requisitions will need to add a signature line, then…
Two Years Later, CMS Still Holds Labs’ Competitive Bid Documents
By Robert Michel | From the Volume XVII No. 6 – April 19, 2010 Issue
IF ACTIONS SPEAK LOUDER THAN WORDS, then the federal government sends a clear message by its repeated refusal to return bidding documents to laboratories involved with the now-defunct Medicare Clinical Laboratory Services Competitive Bidding Demonstration project. That’s because, more than two yea…
New Clinical Lab Trends To Shape Events in 2010
By Robert Michel | From the Volume XVII No. 1 – January 4, 2010 Issue
CEO SUMMARY: In presenting this list of macro trends for clinical laboratories, several themes are in play. They range from a continued emphasis on improving lab operations to the need to acquire and deploy sophisticated information technology. During the next few years, the long…
$750 Million Lab Test Tax Proposed in Senate Bill
By Robert Michel | From the Volume XVI No. 13 – September 21, 2009 Issue
CEO SUMMARY: A bill that may be the U.S. Senate’s framework for reforming the U.S. healthcare system calls for a tax of $750 million per year to be paid by lab testing companies. The proposed bill also calls for a reduction in Medicare reimbursement for lab testing. One positiv…
CMS Refuses to Return Competitive Bid Docs
By Robert Michel | From the Volume XVI No. 7 – May 18, 2009 Issue
CEO SUMMARY: The Acting Secretary of Health and Human Services (HHS) has refused the request of three San Diego-area labs for the return of their bid documents—even though the competitive bidding demonstration project was repealed by Congress last July. The HHS Acting Secretary…
San Diego Labs Pursue Return of Bids from Medicare Officials
By Robert Michel | From the Volume XVI No. 6 – April 27, 2009 Issue
HAVING WON a significant court ruling last spring that stopped the Medicare Laboratory Testing Competitive Bidding Demonstration Project dead in its tracks, three San Diego-area laboratories are scheduled to return to court today. Important legal issues still need resolution. At today’s scheduled …
March 16, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 4 – March 16, 2009 Issue
In the United Kingdom, there is an interesting development regarding anatomic pathology and clinical laboratory services. The trust which operates the famous 986-bed Guy’s Hospital and 957-bed St. Thomas’ Hospital has entered a joint venture with Serco Gr…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized